The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Restructure and Equity Issue

31 Jul 2020 10:45

RNS Number : 7739U
Oilex Ltd
31 July 2020
 

ASX-RNS Announcement

 

 

31 July 2020

 

ASX: OEX

AIM: OEX

Loan Restructure and Equity Issue

 

The Board of Oilex Limited (the Company) is pleased to announce that it has taken further steps to strengthen its balance sheet as the Company continues to navigate the impact of Covid-19 on its business and global equity markets. In particular, the Company has entered into an amendment agreement to vary the repayment obligations for its Series C (GBP£125,000) loan. Furthermore, the Company has secured additional equity investment of £0.25 million to increase its working capital flexibility and reduce its financial debt obligations.

 

Amendment to Series C Loan Funding Agreement (GBP £125,000)

 

Pursuant to the amendment agreement, the loan repayment date has been extended from 1 August 2020 to 31 October 2020. All other terms remain the same and are extended to 31 October 2020, except for the issue of new options with an expiry date of 29 January 2021. A summary of key terms after the amendment are outlined below:

 

Term: 31 October 2020

Interest Rate: 5%

Repayments 100% payable at maturity

Options Issued: 113,636,364 options over ordinary shares

Option Exercise Price: £0.0011 per option

Option Expiry Date: On 29 January 2021

Security: Unsecured

Key Undertakings: Not to dispose of assets having an aggregate value more than A$1 million

Not to incur any financial indebtedness more than A$50,000

Not to incur any aggregate payment or outgoing exceeding A$1 million (except for wages)

 

Customary additional provisions regarding events of default, undertakings, covenants and representations and warranties remain unchanged.

 

The options, which if exercised in their entirety, will result in a cash inflow to the Company of £125,000 (A$224,901). The proceeds from such conversion of options will be applied to the outstanding Series C Loan balance, which is fully drawn down.

 

The issue of the new options is subject to shareholder approval under ASX Listing Rule 7.1 on or before 30 November 2020. Failure to secure shareholder approval will require immediate repayment of the loan principal and accrued interest.

 

Related Party Transaction under AIM

 

Republic Investment Management Pte Ltd (Republic) makes up all of the Series C Loan balance of £125,000. Republic has a shareholding in the Company of 11.88% and is therefore categorised as a Substantial Shareholder of the Company pursuant to the AIM Rules for Companies (AIM Rules). Accordingly, the entering into the amendment agreement with Republic is classified as a related party transaction pursuant to the AIM Rules.

 

 

 

The Directors of the Company, having consulted with Strand Hanson Limited, the Company's Nominated Adviser, consider that the terms of the amendment agreement with Republic are fair and reasonable insofar as the Company's shareholders are concerned.

 

Equity Capital Raising

 

The Company has arranged an equity capital raising, through Novum Securities Limited and to existing institutional shareholders, to secure further funding of £0.25 million (A$0.5 million) through the subscription of 312,500,000 new shares at GBP 0.08 pence (0.144 AUD cents) per share (Subscription).

 

Funds raised from the Subscription are intended to be applied towards increasing the Company's working capital base and debt reduction The additional funding will support the Company's initiative to implement the settlement with GSPC, which has been delayed by the impact from Covid-19. Completion of the Subscription is anticipated on or about 14 August 2020 and is conditional, inter alia, upon admission of the shares the subject of the Subscription to trading on AIM.

 

Pursuant to advisory agreements with Novum, the Company will issue 15,000,000 unlisted options exercisable at 0.08 pence on or before two years following the completion with the capital raising.

 

The shares, the subject of the Subscription, will rank pari passu in all respects with the existing shares. Application will be made in due course to the London Stock Exchange for the shares (Subscription Shares) to be admitted to trading on AIM with a further announcement at that time. The issue of the Subscription Shares is under Listing Rule 7.1 with the applicable Appendix 3B to be submitted shortly.

 

Following admission of the Subscription shares, the Company's share capital and total voting rights will comprise 4,119,629,999 shares. The Company does not hold any shares in treasury. Consequently, 4,119,629,999 is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Managing Director of Oilex, Joe Salomon, said;

 

"The Company continues to see advances in its flagship Cambay gas project in India, the sale of Bhandut together with the spin out of the Cooper Basin albeit the impact of COVID has increased response times in both India and Australia.

 

Reflecting the extended time frames, the Company has taken every step to reduce its costs including a very significant reduction in staff costs and overheads, both in Australia and India. These efforts ensure that the Company's funding requirements are minimised while it implements the settlement with GSPC, sale of Bhandut and the Armour transaction.

 

We remain confident of successful outcome and we thank our shareholders for their ongoing support and patience."

 

For and on behalf of Oilex Ltd

 

 

Joe Salomon

Managing Director

 

 

 

For further information, please contact:

 

Investor Enquires

Oilex Ltd

Joe Salomon

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Novum Securities

Broker

Colin Rowbury

Email: crowbury@novumsecurities.com

Tel: +44 20 7399 9427

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:+ 44 20 7390 0230 UK

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCKKDBQCBKKNON
Date   Source Headline
15th Aug 20187:00 amRNSNotice of General Meeting
13th Aug 20187:30 amRNSRestoration - Oilex Limited
13th Aug 20187:00 amRNSGSPC Event of Default Update & Trading Restoration
10th Aug 201812:35 pmRNSSuspension - Oilex Ltd
10th Aug 20187:00 amRNSTrading Halt
6th Aug 20187:05 amRNSExpiry of Unlisted Options
31st Jul 20187:00 amRNSJune 2018 Quarterly Report
30th Jul 20187:00 amRNSEvent of Default Notice Update
30th Jul 20187:00 amRNSTranche 2 Update
26th Jul 20187:00 amRNSLoan Funding & Cash Call Receipt
29th May 20187:00 amRNSIssue of Event of Default Notice - Cambay PSC
17th May 20187:00 amRNSNotice Change of Interests of Substantial Holder
15th May 20187:00 amRNSAppendix 3Y P Haywood
15th May 20187:00 amRNSAppendix 3Y B Lingo
15th May 20187:00 amRNSAppendix 3B Issue of Shares and Section 708 Notice
30th Apr 201810:19 amRNSMarch 2018 Quarterly Report
30th Apr 201810:11 amRNSCapital Raising and T2 Variation
4th Apr 20187:00 amRNSMoPNG Approves Application for PSC Extensions
29th Mar 20187:00 amRNSAmendment to T2 Capital Raising Conditions
15th Mar 20187:00 amRNSManaging Director Contract Extension
14th Mar 20187:00 amRNSResults of 14 March 2018 General Meeting
1st Mar 20187:00 amRNSAppendix 3Y B Lingo
1st Mar 20187:00 amRNSAppendix 3B Issue of Shares and Section 708 Notice
1st Mar 20187:00 amRNSAppendix 3Y P Haywood
26th Feb 20187:00 amRNSInvestor Presentation February 2018
22nd Feb 20187:47 amRNSInterim Report 31 December 2017
12th Feb 20187:00 amRNSNotice of General Meeting
1st Feb 20187:00 amRNSNotice of Initial Substantial Holder
29th Jan 20187:00 amRNSAppendix 3B Issue of Shares and Section 708 Notice
29th Jan 20187:00 amRNSQuarterly Report 31 December 2017
22nd Dec 20177:00 amRNSExpiry of Unlisted Options
12th Dec 20178:29 amRNSAppendix 3B Issue of Shares and Section 708 Notice
12th Dec 20177:00 amRNSPlacement to New Cornerstone Shareholder
29th Nov 20177:00 amRNSAppendix 3Z M Cozijn
29th Nov 20177:00 amRNSChairman's Address to Shareholders
29th Nov 20177:00 amRNSResults of Annual General Meeting 29 November 2017
23rd Nov 20177:00 amRNSExpiry of Unlisted Options
13th Nov 201712:43 pmRNSInvestor Presentation November 2017
13th Nov 20177:00 amRNSExpiry of Unlisted Options
30th Oct 20177:00 amRNS2017 AGM Notice of Meeting
30th Oct 20177:00 amRNSBoard Changes
30th Oct 20177:00 amRNS2017 Annual Report to Shareholders
26th Oct 20179:50 amRNSQuarterly Report 30 September 2017
13th Sep 20177:00 amRNSCorporate Governance Statement
13th Sep 20177:00 amRNSGood Oil Investor Presentation September 2017
12th Sep 20179:40 amRNSFinancial Report for Year Ended 30 June 2017
12th Sep 20179:31 amRNSAppendix 4G
12th Sep 20179:29 amRNSUpdated Constitution
4th Sep 20178:07 amRNSAppendix 3B Issue of Shares and Section 708 Notice
29th Aug 20177:00 amRNSOilex Investor Presentation August 2017

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.